iron4u granted paediatric investigation plan (PIP)
by EMA for new human IV iron
iron4u was founded in Denmark in 2012 by investors from 5 European countries – including Germany and Denmark.
iron4u’s main focus, in cooperation with the German Company Serumwerk Bernburg, is to develop and register a patented human injectable iron product based on Polyglucoferron and to market the product world-wide.
The company focuses on improving the treatment of iron deficiency for humans. In addition iron4u have marketed products aiming at optimizing treatment of iron deficiency in the veterinary setting.
Discussions with licensing partners are ongoing.